Bioavailability and absorption of ingredients is an important issue for many dietary supplements in the market. The higher the bioavailability of a nutrient, the more that nutrient can be absorbed and benefit the body. For the human body to receive maximum benefits from lipophilic actives (fat-soluble ingredients)—such as Lutein, Resveratrol, Curcumin, and Omega-3s—they must be surrounded with an emulsifier to make them more bioavailable and absorbable.
AquaCelle® is a trademark of Pharmako Biotechnologies Pty Ltd.
AquaCelle® is a lipid based formulation that self-assembles into a micellar colloidal delivery system in aqueous environments (such as the stomach) at body temperature. These micelles are what envelop fat-soluble ingredients, helping their benefits to be absorbed more fully into the body.
The body has its own built-in capacity to make fat-soluble ingredients absorbable. Using the liver to form bile acids and then bile salts, the body then secretes these salts to surround molecules of fat-soluble ingredients to allow them to be absorbed by the small intestine. The formation of micelles is time-consuming and waits on bile salts to form, be secreted, and form micelles before each ingredient can be properly and beneficially absorbed, leaving room for fat-soluble nutrients to be damaged by stomach acids while waiting.
AquaCelle® is designed to more efficiently create these micelles, delivering better absorption and a more efficacious finished product for the consumer.
Our award winning LipiSperse® is an advanced cold water dispersion technology(CWD). Allowing solid lipophilic active ingredients with otherwise relatively low bioavailability & poor solubility in water, to be easily dispersed in cold water, thereby increasing their bioavailability and uptake in the body.
LipiSperse® is a trademark of Pharmako Biotechnologies Pty Ltd.
Pharmako's Compressible Powdered Oils (CPOs) are an ingenious material development that allow oily active ingredients to be included in tablet & powder formulations without leaching of the oil.
Pharmako's CPO Astaxanthin extends the formatting range of this novel ingredient. With our development, astaxanthin is now able to be utilised in tablet & powder formulations with a high 4% concentration and superior stability.
Pharmako's CPO Lavender is a progressive material development that allows lavender oil to be converted into a powder with a 50% loading. The powder is not sensitive to temperature and pressure, with a high linalool and linalyl acetate concentration.